Rohatgi, N., Patil, D. S., Medhi, K., Tiwari, P., Goyal, S., Limaye, S. A., Vijayakumar, R., Sharma, S., Gupta, T. C., Reddy, V. A., Datar, R., Plowman, P. N., Pai, A., Dobosz, P., Kulkarni, S. S., Vamadevan, P., Atreya, H. V., Agarwala, V. (2026). Tumor-agnostic and cross-indication actionable alterations in
                    <i>IDH</i>
                    -wildtype glioma: Precision oncology opportunities in an aggressive disease.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e14060